Search

Displaying results 5881 - 5890 of 10000 in total
  1. Drug

    Fulimetibant

    go.drugbank.com/drugs/DB21599
    Experimental

    The usage of the INN stem '-tibant' in the name indicates that Fulimetibant is a bradykinin receptor antagonist. Fulimetibant has a monoisotopic molecular weight of 487.15 Da.

  2. Drug

    Adrixetinib

    go.drugbank.com/drugs/DB21620
    Investigational

    The usage of the INN stem '-tinib' in the name indicates that Adrixetinib is a tyrosine kinase inhibitor. Adrixetinib has a monoisotopic molecular weight of 531.17 Da.

  3. Drug

    Friluglanstat

    go.drugbank.com/drugs/DB21652
    Experimental

    The usage of the INN stem '-glanstat' in the name indicates that Friluglanstat is a prostaglandin synthase inhibitor. Friluglanstat has a monoisotopic molecular weight of 516.12 Da.

  4. Drug

    Canlitinib

    go.drugbank.com/drugs/DB21656
    Experimental

    The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor. Canlitinib has a monoisotopic molecular weight of 619.21 Da.

  5. Drug

    Labuxtinib

    go.drugbank.com/drugs/DB21658
    Experimental

    The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor. Labuxtinib has a monoisotopic molecular weight of 377.13 Da.

  6. Drug

    Talorasib

    go.drugbank.com/drugs/DB21686
    Experimental

    The usage of the INN stem '-rasib' in the name indicates that Talorasib is a Ras protein inhibitor. Talorasib has a monoisotopic molecular weight of 604.24 Da.

  7. Drug

    Ketanserin

    go.drugbank.com/drugs/DB12465
    Investigational

    Ketanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  8. Drug

    Camibirstat

    go.drugbank.com/drugs/DB21586
    Investigational

    Camibirstat has a monoisotopic molecular weight of 562.17 Da. … Camibirstat is under investigation in clinical trial NCT04891757 (FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies).

  9. Drug

    Oditrasertib

    go.drugbank.com/drugs/DB21526
    Investigational

    Oditrasertib has a monoisotopic molecular weight of 295.11 Da. … Oditrasertib is under investigation in clinical trial NCT05630547 (A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis

  10. Drug

    Dihematoporphyrin ether

    go.drugbank.com/drugs/DB15351
    Investigational

    Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).

    Categories: Heterocyclic Compounds with 4 or More Rings